» Articles » PMID: 28652336

Structure of Human NSMase2 Reveals an Interdomain Allosteric Activation Mechanism for Ceramide Generation

Overview
Specialty Science
Date 2017 Jun 28
PMID 28652336
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Neutral sphingomyelinase 2 (nSMase2, product of the gene) is a key enzyme for ceramide generation that is involved in regulating cellular stress responses and exosome-mediated intercellular communication. nSMase2 is activated by diverse stimuli, including the anionic phospholipid phosphatidylserine. Phosphatidylserine binds to an integral-membrane N-terminal domain (NTD); however, how the NTD activates the C-terminal catalytic domain is unclear. Here, we identify the complete catalytic domain of nSMase2, which was misannotated because of a large insertion. We find the soluble catalytic domain interacts directly with the membrane-associated NTD, which serves as both a membrane anchor and an allosteric activator. The juxtamembrane region, which links the NTD and the catalytic domain, is necessary and sufficient for activation. Furthermore, we provide a mechanistic basis for this phenomenon using the crystal structure of the human nSMase2 catalytic domain determined at 1.85-Å resolution. The structure reveals a DNase-I-type fold with a hydrophobic track leading to the active site that is blocked by an evolutionarily conserved motif which we term the "DK switch." Structural analysis of nSMase2 and the extended N-SMase family shows that the DK switch can adopt different conformations to reposition a universally conserved Asp (D) residue involved in catalysis. Mutation of this Asp residue in nSMase2 disrupts catalysis, allosteric activation, stimulation by phosphatidylserine, and pharmacological inhibition by the lipid-competitive inhibitor GW4869. Taken together, these results demonstrate that the DK switch regulates ceramide generation by nSMase2 and is governed by an allosteric interdomain interaction at the membrane interface.

Citing Articles

Role of Acorus calamus extract in reducing exosome secretion by targeting Rab27a and nSMase2: a therapeutic approach for breast cancer.

Gupta S, Gupta S, Singh M, Patel A Mol Biol Rep. 2025; 52(1):124.

PMID: 39812915 DOI: 10.1007/s11033-024-10203-6.


Recent Advances of Small Extracellular Vesicles for the Regulation and Function of Cancer-Associated Fibroblasts.

Liang C, Wang M, Huang Y, Yam J, Zhang X, Zhang X Int J Mol Sci. 2024; 25(23).

PMID: 39684264 PMC: 11641781. DOI: 10.3390/ijms252312548.


Exploring the Role of SMPD3 in the lncRNA-miRNA-mRNA Regulatory Network in TBI Progression by Influencing Energy Metabolism.

Cui C, Xu B, Liu H, Wang C, Zhang T, Jiang P J Inflamm Res. 2024; 17:10835-10848.

PMID: 39677286 PMC: 11646434. DOI: 10.2147/JIR.S491290.


Prophages divert Staphylococcus aureus defenses against host lipids.

Zhou B, Pathania A, Pant D, Halpern D, Gaudu P, Trieu-Cuot P J Lipid Res. 2024; 65(12):100693.

PMID: 39505263 PMC: 11721228. DOI: 10.1016/j.jlr.2024.100693.


The Immobilization of an FGF2-Derived Peptide on Culture Plates Improves the Production and Therapeutic Potential of Extracellular Vesicles from Wharton's Jelly Mesenchymal Stem Cells.

Lee Y, Lim K, Bong H, Lee S, Jeon T, Lee S Int J Mol Sci. 2024; 25(19).

PMID: 39409038 PMC: 11477336. DOI: 10.3390/ijms251910709.


References
1.
Montecalvo A, Larregina A, Shufesky W, Stolz D, Sullivan M, Karlsson J . Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 2011; 119(3):756-66. PMC: 3265200. DOI: 10.1182/blood-2011-02-338004. View

2.
Dinkins M, Dasgupta S, Wang G, Zhu G, Bieberich E . Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2014; 35(8):1792-800. PMC: 4035236. DOI: 10.1016/j.neurobiolaging.2014.02.012. View

3.
Shamseddine A, Clarke C, Carroll B, Airola M, Mohammed S, Rella A . P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest. Cell Death Dis. 2015; 6:e1947. PMC: 4632297. DOI: 10.1038/cddis.2015.268. View

4.
Lyon A, Begley J, Manett T, Tesmer J . Molecular mechanisms of phospholipase C β3 autoinhibition. Structure. 2014; 22(12):1844-1854. PMC: 4308481. DOI: 10.1016/j.str.2014.10.008. View

5.
Kim W, Okimoto R, Purton L, Goodwin M, Haserlat S, Dayyani F . Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood. 2008; 111(9):4716-22. PMC: 2343601. DOI: 10.1182/blood-2007-10-113068. View